List your tool

Head to head · 2026

NeuroClues vs ThinkSono

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

NeuroClues

Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis

4.3Not listed

Visit NeuroClues (opens NeuroClues in a new tab)

ThinkSono

Guides a nurse through a DVT ultrasound in real time, cutting the pathway to 30 minutes

4.1Not listed

Visit ThinkSono (opens ThinkSono in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: NeuroClues does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    NeuroClues

    4.3 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onNeuroCluesThinkSono
Our rating4.3Better4.1
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Portable, CE-marked Class IIa medical device for clinical eye-movement recording
  • Calibration-free patient setup using dual infrared cameras at 400 fps
  • AI-derived biomarkers benchmarked against reference ranges for clinical interpretation
  • Early-detection targeting for Parkinson's, Alzheimer's, and multiple sclerosis
  • Deployment across university hospitals and private neurology practices in seven-plus countries
  • Real-time guidance for probe positioning and anatomy
  • Proximal compression ultrasound for DVT
  • Designed for non-ultrasound-trained clinicians
  • Scan upload and automated reporting
  • CE Class IIb marked for EU and UK use
Pros
  • CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise
  • More than €22 million raised, including a €10 million Series A, signals investor confidence
  • Aims at detection years before visible symptoms, where neurological treatment has the most impact
  • Compresses a day-long diagnostic pathway to about 30 minutes
  • Puts the scan in the hands of the clinician already with the patient
  • CE Class IIb marking rather than research-only status
Cons
  • No published pricing, and as a clinical device it is sold directly to institutions, not individuals
  • Limited so far to the European market and CE marking, without confirmed FDA clearance
  • As a diagnostic aid, findings still require a neurologist's clinical interpretation, not a standalone verdict
  • Not FDA approved, so unavailable clinically in the United States
  • No published pricing
  • Guided scanning still depends on the operator's hand
CompanyneuroClues, founded 2020ThinkSono GmbH

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is NeuroClues better than ThinkSono?

In our reviews NeuroClues scores 4.3 and ThinkSono scores 4.1. The better pick depends on the job. NeuroClues: Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis. ThinkSono: Guides a nurse through a DVT ultrasound in real time, cutting the pathway to 30 minutes.

Which is cheaper, NeuroClues or ThinkSono?

NeuroClues: see pricing. ThinkSono: see pricing.

Do NeuroClues and ThinkSono have free plans?

Neither lists a free plan.

More comparisons